Antibody Technologies
In this product category, you will find reports and other services providing you with the most uptodate business and competitive intelligence information on antibodies and antibody technologies. The range of products covers industry data as well as in-depth strategic assessment and analysis of antibody technologies, R&D pipeline, and sales and market data.
Subscribe to
our newsletters!
Showing all 15 results
- Degrader-Antibody Conjugates 2024: Stakeholders, Technologies, Pipeline and Deals€ 2050.00
- This product provides basic information on antibody therapy candidates in R&D targeting EpCAM.€ 200.00
- This report provides a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell therapy candidates from an industry perspective as of August 2023€ 1720.00
- Antibody Target, Technology & Pipeline Database€ 1600.00
- This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on-target/off-tumor toxicity.€ 1800.00
- The report evaluates opportunities for GPRC5D-targeted drug modalities within the competitive landscape.€ 600.00
- This report describes and analyzes claudin 6 as a target opportunity for development of effector-enhanced drug modalities€ 500.00
- Package of two reports with emerging evolutionary technologies of Vectorized Antibodies and Prodrug Antibodies & Cytokines€ 2200.00
- Landscape description and analysis of prodrug antibodies and cytokines employing conventional and novel masking technologies from an industry perspective as of October 2021€ 2250.00
- This report provides you with a landscape description and analysis of direct in vivo delivery of nucleic acid-encoded antibodies employing DNA and mRNA platform technologies from an industry perspective as...€ 2150.00
- Package of two reports with in depth analysis of T-cell and NK cell engaging bispecific antibodies and competitor analysis of 271 unique bispecific antibody-based constructs€ 2500.00
- This report evaluates the competitive landscape of investigational bispecific antibodies for treatment of cancer and other diseaseas as of June 2019.€ 800.00
- This report provides you with a landscape description and analysis of T-cell and natural killer (NK) cell engaging bispecific antibodies as of June 2019.€ 2350.00
- These reports evaluate the competitive landscape of T-Cell Receptor (TCR)-based therapeutic cells and recombinant antibodies or antibody fusion proteins.€ 2670.00
- This report informs you about key technologies to identify and validate intracellular targets, to generate TCRs and TCR fusion proteins, to discover TCR-like antibodies, and construct cell-penetrating peptides, proteins and...€ 2000.00